Total
0
Shares
Therma Bright - CEO, Rob Fia
CEO, Rob Fia
Source: Stockhouse
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Therma Bright (THRM) has uplisted from the OTC Pink Sheets to the OTCQB® Venture Market under the symbol TBRIF
  • OTCQB listing offers the company enhanced visibility within the U.S. investment community
  • The OTCQB is recognized by the United States Securities and Exchange Commission as an established public market
  • Therma Bright is a progressive medical device technology company
  • Therma Bright Inc. (THRM) opened trading at C$0.47 per share

Therma Bright (THRM) has uplisted from the OTC Pink Sheets to the OTCQB® Venture Market.

Therma Bright began trading on the OTCQB today under the symbol TBRIF.

“We’re excited to be up-listed to the OTCQB, which is an important milestone for Therma Bright,” shared Rob Fia, CEO of Therma Bright.

“The OTCBQ affords us greater visibility within the U.S. investment community, which should enhance our liquidity and increase our access to institutional and retail investors. This additional capital markets exposure will be invaluable as we continue to buildout our AcuVid™, Venowave, Benepod™ and other product lines, along with their U.S. and global distribution sales channels.”

The OTCQB is designed for developing and entrepreneurial companies in the United States and abroad.

The OTCQB is recognized by the United States Securities and Exchange Commission as an established public market providing public information for the analysis and value of securities. 

Therma Bright is a medical device technology company focused on providing consumers and medical professionals with medical devices that address medical and healthcare needs.

Therma Bright Inc. (THRM) opened trading at C$0.47 per share.

More From The Market Herald
Amarillo Gold - Eric Sprott.

" Eric Sprott supports Hochschild Mining’s acquisition of Amarillo Gold (TSXV:AGC)

Eric Sprott has announced his voting support agreement for Hochschild’s acquisition of Amarillo Gold (AGC).
BioMark Diagnostics - Founder and CEO, Rashid Bux

" BioMark (CSE:BUX) to collaborate with AstraZeneca and Pfizer Canada to improve early detection of lung cancer

BioMark Diagnostics (BUX) will participate in a research project that aims to enhance the efficiency of lung cancer screening programs.

" Algernon Pharmaceuticals (CSE:AGN) welcomes new CFO

Algernon Pharmaceuticals (AGN) has appointed Mr. James Kinley as the Chief Financial Officer (CFO), effective December 1, 2021.

" Beyond Medical Technologies (CSE:DOCT) ramps up mask manufacturing in response to new South African variant

Beyond Medical Technologies (DOCT) subsidiary Micron Technologies has been manufacturing medical masks in British Columbia since August 2020.